|
Lesions
|
Total (n = 139)
|
%
|
|---|
|
Number of lesions:
| | |
|
Hepatic metastases
|
113
|
81%
|
|
Lung metastases
|
26
|
19%
|
|
Lesion diameter, median (range):
| | |
|
Liver (n = 111)
|
28 mm
|
(range 7–100)
|
|
Lung (n = 26)
|
12.5 mm
|
(range 5–63.5)
|
|
Previous local treatment to hepatic lesions
|
68
|
60%
|
|
Local hepatic treatment:
| | |
|
Surgery of same lesion
|
2
|
2%
|
|
Surgery of other lesions
|
49
|
44%
|
|
Chemo-embolisation
|
3
|
3%
|
|
Radio-frequency
|
14
|
12%
|
|
Response (RECIST)
| | |
|
Hepatic metastases
| | |
|
CR
|
56
|
51%
|
|
PR
|
22
|
20%
|
|
SD
|
10
|
9%
|
|
PD
|
22
|
20%
|
|
Response
| | |
|
Lung metastases
| | |
|
CR
|
14
|
58%
|
|
PR
|
2
|
8%
|
|
SD
|
1
|
4%
|
|
PD
|
7
|
29%
|
|
Response
| | |
|
All lesions
| | |
|
CR
|
70
|
52%
|
|
PR
|
24
|
18%
|
|
SD
|
11
|
9%
|
|
PD
|
29
|
20%
|
